Repare Therapeutics Inc (RPTX) — Cash Flow Reinvestment Rate
Repare Therapeutics Inc (RPTX) has a Cash Flow Reinvestment Rate of 0.96x as of September 2025, reinvesting $2.54 Million (capex $0.00 plus investments $2.54 Million) from operating cash flow of $2.65 Million. Explore Repare Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Repare Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Repare Therapeutics Inc across 1 annual periods. Also explore how large is Repare Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Repare Therapeutics Inc (2022–2022)
Year-by-year capital reinvestment analysis for Repare Therapeutics Inc. For live market cap and broader valuation context, see RPTX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 547.76x | $176.38 Million | $322.00K | $602.00K | — |